(S (NP (NP (NN Classification)) (PP (IN of) (NP (NP (NN histologic) (NNS patterns)) (PP (IN in) (NP (NN lung) (NN adenocarcinoma)))))) (VP (VBZ is) (ADJP (JJ critical) (PP (IN for) (S (VP (VBG determining) (NP (NP (NN tumor) (NN grade)) (CC and) (NP (NP (NN treatment)) (PP (IN for) (NP (NNS patients)))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (DT this) (NN task)) (VP (VBZ is) (ADVP (RB often)) (ADJP (VBG challenging)) (PP (JJ due) (TO to) (NP (NP (NP (DT the) (JJ heterogeneous) (NN nature)) (PP (IN of) (NP (NN lung) (NN adenocarcinoma)))) (CC and) (NP (NP (DT the) (JJ subjective) (NNS criteria)) (PP (IN for) (NP (NN evaluation))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (JJ deep) (NN learning) (NN model)) (SBAR (WHNP (WDT that)) (S (VP (ADVP (RB automatically)) (VBZ classifies) (NP (NP (DT the) (NN histologic) (NNS patterns)) (PP (IN of) (NP (NN lung) (NN adenocarcinoma))) (PP (IN on) (NP (JJ surgical) (NN resection) (NNS slides))))))))) (. .))
(S (NP (PRP$ Our) (NN model)) (VP (VP (VBZ uses) (NP (DT a) (JJ convolutional) (JJ neural) (NN network)) (S (VP (TO to) (VP (VB identify) (NP (NP (NNS regions)) (PP (IN of) (NP (JJ neoplastic) (NNS cells)))))))) (, ,) (RB then) (VP (VBZ aggregates) (NP (DT those) (NNS classifications)) (S (VP (TO to) (VP (VB infer) (NP (NP (ADJP (JJ predominant) (CC and) (JJ minor)) (NN histologic) (NNS patterns)) (PP (IN for) (NP (DT any) (VBN given) (JJ whole-slide) (NN image))))))))) (. .))
(S (NP (PRP We)) (VP (VBD evaluated) (NP (PRP$ our) (NN model)) (PP (IN on) (NP (NP (DT an) (JJ independent) (NN set)) (PP (IN of) (NP (CD 143) (JJ whole-slide) (NNS images)))))) (. .))
(S (NP (PRP It)) (VP (VBD achieved) (NP (NP (NP (DT a) (NN kappa) (NN score)) (PP (IN of) (NP (CD 0.525)))) (CC and) (NP (NP (DT an) (NN agreement)) (PP (IN of) (NP (CD 66.6) (NN %))) (PP (IN with) (NP (CD three) (NNS pathologists))) (PP (IN for) (S (VP (VBG classifying) (NP (DT the) (NN predominant) (NNS patterns)))))) (, ,) (ADJP (ADJP (RB slightly) (JJR higher)) (PP (IN than) (NP (NP (NP (DT the) (JJ inter-pathologist) (NN kappa) (NN score)) (PP (IN of) (NP (CD 0.485)))) (CC and) (NP (NP (NN agreement)) (PP (IN of) (NP (CD 62.7) (NN %)))) (PP (IN on) (NP (DT this) (NN test) (NN set)))))))) (. .))
(S (NP (NP (DT All) (NN evaluation) (NNS metrics)) (PP (IN for) (NP (NP (PRP$ our) (NN model)) (CC and) (NP (DT the) (CD three) (NNS pathologists))))) (VP (VBD were) (PP (IN within) (NP (NP (ADJP (CD 95) (NN %)) (NN confidence) (NNS intervals)) (PP (IN of) (NP (NN agreement)))))) (. .))
(S (SBAR (IN If) (S (VP (VBN confirmed) (PP (IN in) (NP (JJ clinical) (NN practice)))))) (, ,) (NP (PRP$ our) (NN model)) (VP (MD can) (VP (VB assist) (NP (NNS pathologists)) (PP (IN in) (S (VP (VBG improving) (NP (NP (NN classification)) (PP (IN of) (NP (NN lung) (NN adenocarcinoma) (NNS patterns))))))) (PP (IN by) (S (ADVP (RB automatically)) (VP (JJ pre-screening) (CC and) (VBG highlighting) (NP (JJ cancerous) (NNS regions)) (ADVP (RB prior) (PP (TO to) (NP (VB review))))))))) (. .))
(S (S (NP (PRP$ Our) (NN approach)) (VP (MD can) (VP (VB be) (VP (VBN generalized) (PP (TO to) (NP (DT any) (JJ whole-slide) (NN image) (NN classification) (NN task))))))) (, ,) (CC and) (S (NP (NN code)) (VP (VBZ is) (VP (VBN made) (S (ADJP (RB publicly) (JJ available))) (PP (IN at) (NP (DT this) (NN https) (NNP URL)))))))
